An outbreak of novel betacoronavirus, SARS-CoV-2 (formerly named 2019-nCoV), began in Wuhan, China in December 2019 and the COVID-19 disease associated with infection has since spread rapidly to multiple countries. Here we report the development of SARS-CoV-2 DETECTR, a rapid (~30 min), low-cost, and accurate CRISPR-Cas12 based lateral flow assay for detection of SARS-CoV-2 from respiratory swab RNA extracts. We validated this method using contrived reference samples and clinical samples from infected US patients and demonstrated comparable performance to the US CDC SARS-CoV-2 real-time RT-PCR assay.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239074 | PMC |
| http://dx.doi.org/10.1101/2020.03.06.20032334 | DOI Listing |
Publication Analysis
Top Keywords
lateral flow
8
flow assay
8
sars-cov-2
5
rapid detection
4
detection 2019
4
2019 novel
4
novel coronavirus
4
coronavirus sars-cov-2
4
sars-cov-2 crispr-based
4
crispr-based detectr
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!